Molecular portraits of human breast tumours

Charles M. Perou, Thérese Sørlie, Michael B. Eisen, +15

Nature

Breast OncologyEndocrine-related CancerPathologyBreast CancerMedicine +3

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani, +14

Proceedings of the National Academy of Sciences

Repeated observation of breast tumor subtypes in independent gene expression data sets

Thérese Sørlie, Robert Tibshirani, Joel S. Parker, +13

Proceedings of the National Academy of Sciences

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Turid Aas, Anne‐Lise Børresen, Stephanie Geisler, +5

Nature Medicine

Breast OncologyBreast Cancer PatientsMedicinePathologyCancer Genomics +7

Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Jonathan R. Pollack, Charles M. Perou, Thérese Sørlie, +13

Nature Genetics

Breast OncologyTumor HeterogeneityMedicineGeneticsDna Microarrays +7

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

Thérese Sørlie, Yulei Wang, Chunlin Xiao, +4

BMC Genomics

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Stephanie Geisler, Per Eystein Lønning, Turid Aas, +5

PubMed

Breast OncologyC-erbb-2 ExpressionPathologyCancer BiologyTumor Biology +16

miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors

Espen Enerly, Israel Steinfeld, Kristine Kleivi Sahlberg, +14

PLoS ONE

Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers

Åslaug Helland, Michael S. Anglesio, Joshy George, +12

PLoS ONE

Systems BiologyEngineeringMolecular SubtypesTumor HeterogeneityMolecular Subtype +13

TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.

Stephanie Geisler, Anne‐Lise Børresen‐Dale, Hilde Johnsen, +5

PubMed